Jeff Smaill


Dr. Jeff Smaill is an a associate professor at the Auckland Cancer Society Research Centre at the University of Auckland and an associate investigator of the Maurice Wilkins Centre for Molecular Biodiscovery. Dr. Smaill has extensive experience in the design and synthesis of ATP-competitive small molecule kinase inhibitors and is currently interested in developing the next generation of bioreductive prodrugs with a focus on using a hypoxia-activated prodrug strategy to impart increased tumor-selectivity to novel multikinase inhibitors.

Dr. Smaill obtained his BS and PhD degrees in the field of synthetic organic chemistry from the University of Otago in New Zealand.